Outlook Therapeutics, Inc. (OTLK) NASDAQ

2.05

+0.08(+4.06%)

Updated at July 30 04:00PM

Currency In USD

Valuation

Market Cap99.05M
Enterprise Value113.86M
P/E Ratio3
PEG Ratio0.02
Price/Sales Ratio0
Price/Book Ratio-1.95
Enterprise/Revenue0
Enterprise/EBITDA7.01

Fiscal Year

Fiscal YearSeptember 30, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets1.11
Return On Equity-0.35

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-71.59M
Net Income-75.37M
Diluted EPS-9.76

Balance Sheet

Total Cash7.56M
Total Cash/Share0.24
Total Debt33.32M
Total Debt/Equity-1.03
Current Ratio0.72
Book Value Per Share-1.05

Price History

52-Week Change-73.55
52-Week High8.32
52-Week Low0.87
Moving Average 50 Days1.87
Moving Average 200 Days2.37

Statistics

Average Volume802,425
Shares Outstanding42.85M
% Held by Institutions22.95

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateMarch 14, 2024